Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04999007 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Artificial Intelligence Assists Surgeons' Decision Making

StatusCompleted
PhaseNot applicable
SponsorJichao Qin
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Final enrollment: 872 participants (planned 616)
    • Primary completion date changed from estimate of Sep 2025 to Mar 17, 2025
    • Eligibility criteria expanded, about 10 words
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Primary completion date: Sep 2024 to Sep 2025
    • Study completion date: Oct 2024 to Oct 2025
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Enrollment target: 872 to 616v3
  5. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Aug 31, 2024 to Sep 2024
    • Study completion date: Oct 1, 2024 to Oct 2024
    • Start date changed from estimate of Aug 31, 2021 to Sep 2, 2021
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Jichao Qin
7 trials monitored
See 1 trial at risk
Colorectal Cancer
3,394 trials monitored
See 159 trials at risk
This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.
Trial Details
NCT Number NCT04999007
Lead Sponsor Jichao Qin
Conditions
(from sponsor)		 Rectal Cancer
Related terms Anastomotic Leak, Rectal Neoplasms
Enrollment 872 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov